Reply to the Letter "Effect of anti-oxidant agents in patients with hepatocellular diseases"

Affiliations

Free article

Comment

R Aller et al. Eur Rev Med Pharmacol Sci. 2015 Nov.

Free article

. 2015 Nov;19(21):3996-7.

¹ Svo. Gastroenterology, Hospital Clínico Universitario, University of Valladolid, Valladolid, Spain. roaller@yahoo.es.

No abstract available

Comment on

Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
Aller R, Izaola O, Gómez S, Tafur C, González G, Berroa E, Mora N, González JM, de Luis DA. Aller R, et al. Eur Rev Med Pharmacol Sci. 2015 Aug;19(16):3118-24. Eur Rev Med Pharmacol Sci. 2015. PMID: 26367736 Clinical Trial.
Effect of anti-oxidant agents in patients with hepatocellular diseases.
Di Francia R, Rinaldi L, Troisi A, Di Benedetto F, Berretta M. Di Francia R, et al. Eur Rev Med Pharmacol Sci. 2015 Nov;19(21):3993-5. Eur Rev Med Pharmacol Sci. 2015. PMID: 26592818 No abstract available.